Beta Bionics, Inc.
Beta Bionics, Inc.（BBNX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
bbnx · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Buy
8 位分析师
共识
评级分布
12 个月目标价
High
$25.00
Consensus
$19.86
+39.8% upside
Low
$14.00
Median: $20 · Last Close: $14.20
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$19.86
39.8% upside
High Target
$25
76.0%
Low Target
$14
-1.4%
Current Price
$14.20
as of today
Based on analyst price targets, the BBNX stock price prediction for the next 12 months ranges from $14 to $25. The consensus BBNX price forecast of $19.86 implies 39.8% upside from the current price of $14.20.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $14.91 | ↑ 5.00% |
1-day model range: $14.79–$15.04. Peak: $15.04 (+5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | -45.5% |
| 2028 | $6 | -59.1% |
| 2029 | $5 | -64.7% |
| 2030 | $5 | -67.4% |
| 2031 | — | -68.8% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BBNX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-27 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-05-18 | B of A Securities | Maintains | Neutral→Neutral |
| 2026-04-22 | Stifel | Maintains | Buy→Buy |
| 2026-04-22 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-04-15 | Truist Securities | Maintains | Buy→Buy |
| 2026-04-09 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-02-18 | Baird | Maintains | Neutral→Neutral |
| 2026-02-18 | Stifel | Maintains | Buy→Buy |
| 2026-02-04 | Stifel | Maintains | Buy→Buy |
| 2026-02-02 | Truist Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Beta Bionics, Inc. (BBNX) stock. Of the recent 21 rating actions, 1 were upgrades and 0 were downgrades. 8 analysts currently cover BBNX.
分析师推荐趋势
BBNX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 5 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$134M
↓ 47.0% YoY
Revenue Next Year
$181M
↑ 35.2% YoY
EPS This Year
$-2.16
EPS Next Year
$-2.11
↓ 2.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast BBNX EPS of $-2.16 for the current fiscal year, based on estimates from 6 analysts. The BBNX revenue forecast is $134M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
BBNX 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。BBNX 的共识目标价为 $19.86（+39.8% 上行空间），分析师共识为 Buy。
BBNX 的短期预测（明日）为 $14.91（+5.00%）。 BBNX 对 2027 年的股价预测均值为 $8。 BBNX 对 2030 年的预测区间为 $4–$5。
Beta Bionics, Inc. 在 NASDAQ 上市，代码 BBNX。BBNX 在 2027 年的整体展望偏积极，在覆盖分析师中约 75% 对应 Buy 共识。
常见问题
BBNX 预测 · 8 个问题根据 8 位华尔街分析师，BBNX 的 12 个月平均目标价为 $19.86，最高 $25.00、最低 $14.00。若有图表，中位目标价可在上方查看。相对当前价 $14.20，隐含约 +39.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.